234 related articles for article (PubMed ID: 33066044)
21. The Inhibitory Effect of Some Drugs on
Serseg T; Benarous K
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):602-609. PubMed ID: 29557755
[TBL] [Abstract][Full Text] [Related]
22. Carboxylated aurone derivatives as potent inhibitors of xanthine oxidase.
Muzychka OV; Kobzar OL; Popova AV; Frasinyuk MS; Vovk AI
Bioorg Med Chem; 2017 Jul; 25(14):3606-3613. PubMed ID: 28545814
[TBL] [Abstract][Full Text] [Related]
23. Anti-obesity, antioxidant and in silico evaluation of Justicia carnea bioactive compounds as potential inhibitors of an enzyme linked with obesity: Insights from kinetics, semi-empirical quantum mechanics and molecular docking analysis.
Anigboro AA; Avwioroko OJ; Akeghware O; Tonukari NJ
Biophys Chem; 2021 Jul; 274():106607. PubMed ID: 33957576
[TBL] [Abstract][Full Text] [Related]
24. Cryptotanshinone and tanshinone IIA from
Marrelli M; Grande F; Occhiuzzi MA; Maione F; Mascolo N; Conforti F
Nat Prod Res; 2021 Mar; 35(5):863-866. PubMed ID: 31104489
[No Abstract] [Full Text] [Related]
25. Design, synthesis and biological evaluation of novel chalcone-like compounds as potent and reversible pancreatic lipase inhibitors.
Huo PC; Hu Q; Shu S; Zhou QH; He RJ; Hou J; Guan XQ; Tu DZ; Hou XD; Liu P; Zhang N; Liu ZG; Ge GB
Bioorg Med Chem; 2021 Jan; 29():115853. PubMed ID: 33214035
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic lipase inhibitory effects of peptides derived from sesame proteins: In silico and in vitro analyses.
Wang X; Ai X; Zhu Z; Zhang M; Pan F; Yang Z; Wang O; Zhao L; Zhao L
Int J Biol Macromol; 2022 Dec; 222(Pt A):1531-1537. PubMed ID: 36195236
[TBL] [Abstract][Full Text] [Related]
27. Slowing down fat digestion and absorption by an oxadiazolone inhibitor targeting selectively gastric lipolysis.
Point V; Bénarouche A; Zarrillo J; Guy A; Magnez R; Fonseca L; Raux B; Leclaire J; Buono G; Fotiadu F; Durand T; Carrière F; Vaysse C; Couëdelo L; Cavalier JF
Eur J Med Chem; 2016 Nov; 123():834-848. PubMed ID: 27543878
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of pancreatic lipase by the constituents in St. John's Wort: In vitro and in silico investigations.
Hou XD; Guan XQ; Cao YF; Weng ZM; Hu Q; Liu HB; Jia SN; Zang SZ; Zhou Q; Yang L; Ge GB; Hou J
Int J Biol Macromol; 2020 Feb; 145():620-633. PubMed ID: 31883893
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic lipase inhibitors: The road voyaged and successes.
Kumar A; Chauhan S
Life Sci; 2021 Apr; 271():119115. PubMed ID: 33515565
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, biological evaluation and molecular modelling studies of novel diaryl substituted pyrazolyl thiazolidinediones as potent pancreatic lipase inhibitors.
S N C S; Bhurta D; Kantiwal D; George G; Monga V; Paul AT
Bioorg Med Chem Lett; 2017 Aug; 27(16):3749-3754. PubMed ID: 28705641
[TBL] [Abstract][Full Text] [Related]
31. Discovery of thiazolidinedione-based pancreatic lipase inhibitors as anti-obesity agents: synthesis,
Dhiman P; Yadav N; Auti PS; Jaswal S; Singh G; Mehan S; Ghosh B; Paul AT; Monga V
J Biomol Struct Dyn; 2024 Feb; ():1-23. PubMed ID: 38315459
[TBL] [Abstract][Full Text] [Related]
32. Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism.
Liu PK; Weng ZM; Ge GB; Li HL; Ding LL; Dai ZR; Hou XD; Leng YH; Yu Y; Hou J
Int J Biol Macromol; 2018 Oct; 118(Pt B):2216-2223. PubMed ID: 30009906
[TBL] [Abstract][Full Text] [Related]
33. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
34. A computational study to probe the binding aspects of potent polyphenolic inhibitors of pancreatic lipase.
Kottekad S; Roy S; Dandamudi U
J Biomol Struct Dyn; 2024 Apr; 42(7):3472-3491. PubMed ID: 37199285
[TBL] [Abstract][Full Text] [Related]
35. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
Thillainayagam M; Malathi K; Ramaiah S
J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
[TBL] [Abstract][Full Text] [Related]
36. Molecular recognition between pancreatic lipase and natural and synthetic inhibitors.
Bello M; Basilio-Antonio L; Fragoso-Vázquez J; Avalos-Soriano A; Correa-Basurto J
Int J Biol Macromol; 2017 May; 98():855-868. PubMed ID: 28212930
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel pancreatic lipase inhibitors: Biological investigation and
Mermer A; Demirci S; Tatar G
J Biomol Struct Dyn; 2022 Feb; 40(2):931-940. PubMed ID: 35068360
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Biological Activity and Molecular Docking Studies of Novel Sulfonate Derivatives Bearing Salicylaldehyde.
Korkmaz A; Bursal E
Chem Biodivers; 2022 Jun; 19(6):e202200140. PubMed ID: 35561156
[TBL] [Abstract][Full Text] [Related]
39. Comparative study on inhibitory effects of ginsenosides on human pancreatic lipase and porcine pancreatic lipase: structure-activity relationships and inhibitory mechanism.
Wang AQ; Wang YJ; Zhang J; Fan YM; Li SY; Zou LW
Nat Prod Res; 2024 Jun; 38(12):2031-2039. PubMed ID: 37471672
[TBL] [Abstract][Full Text] [Related]
40. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
